Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |